Literature DB >> 15290846

Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association.

Muppalla Sukumar1, Brandon L Doyle, Jessica L Combs, Allen H Pekar.   

Abstract

PURPOSE: Therapeutic antibodies are often formulated at a high concentration where they may have an opalescent appearance. The aim of this study is to understand the origin of this opalescence, especially its relationship to noncovalent association and physical stability.
METHODS: The turbidity and the association state of an IgG1 antibody were investigated as a function of concentration and temperature using static and dynamic light scattering, nephelometric turbidity, and analytical ultracentrifugation. RESULTS. The antibody had increasingly opalescent appearance in the concentration range 5-50 mg/ml. The opalescence was greater at refrigerated temperature but was readily reversible upon warming to room temperature. Turbidity measured at 25 degrees C was linear with concentration, as expected for Rayleigh scatter in the absence of association. In the concentration range 1-50 mg/ml, the weight average molecular weights were close to that expected for a monomer. Zimm plot analysis of the data yielded a negative second virial coefficient, indicative of attractive solute-solute interactions. The hydrodynamic diameter was independent of concentration and remained unchanged as a function of aging at room temperature.
CONCLUSIONS: The results indicate that opalescent appearance is not due to self-association but is a simple consequence of Rayleigh scatter. Opalescent appearance did not result in physical instability.

Mesh:

Substances:

Year:  2004        PMID: 15290846     DOI: 10.1023/b:pham.0000032993.98705.73

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  A comparative study on viscosity of human, bovine and pig IgG immunoglobulins in aqueous solutions.

Authors:  K Monkos; B Turczynski
Journal:  Int J Biol Macromol       Date:  1999-11       Impact factor: 6.953

2.  Direct observation of the self-association of dilute proteins in the presence of inert macromolecules at high concentration via tracer sedimentation equilibrium: theory, experiment, and biological significance.

Authors:  G Rivas; J A Fernandez; A P Minton
Journal:  Biochemistry       Date:  1999-07-20       Impact factor: 3.162

Review 3.  Quantitative characterization of reversible macromolecular associations via sedimentation equilibrium: an introduction.

Authors:  A P Minton
Journal:  Exp Mol Med       Date:  2000-03-31       Impact factor: 8.718

Review 4.  Monoclonal antibodies in immune and inflammatory diseases.

Authors:  Evangelos Andreakos; Peter C Taylor; Marc Feldmann
Journal:  Curr Opin Biotechnol       Date:  2002-12       Impact factor: 9.740

Review 5.  Bioequivalence and the immunogenicity of biopharmaceuticals.

Authors:  Huub Schellekens
Journal:  Nat Rev Drug Discov       Date:  2002-06       Impact factor: 84.694

Review 6.  Rational design and engineering of therapeutic proteins.

Authors:  Shannon A Marshall; Greg A Lazar; Arthur J Chirino; John R Desjarlais
Journal:  Drug Discov Today       Date:  2003-03-01       Impact factor: 7.851

Review 7.  Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions.

Authors:  J Wen; T Arakawa; J S Philo
Journal:  Anal Biochem       Date:  1996-09-05       Impact factor: 3.365

8.  Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex.

Authors:  D L Bakaysa; J Radziuk; H A Havel; M L Brader; S Li; S W Dodd; J M Beals; A H Pekar; D N Brems
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

Review 9.  Monomeric insulins and their experimental and clinical implications.

Authors:  J Brange; D R Owens; S Kang; A Vølund
Journal:  Diabetes Care       Date:  1990-09       Impact factor: 19.112

10.  Deuterium MR spectroscopy at 4.7 T. Quantification of tumour and subcutaneous tissue blood flow in animal models.

Authors:  R Wirestam; V A Larsen; M Stubgaard; C Thomsen; B Vikhoff; H B Larsson; F Ståhlberg; O Henriksen
Journal:  Acta Radiol       Date:  1995-01       Impact factor: 1.990

View more
  15 in total

1.  High-throughput analysis of concentration-dependent antibody self-association.

Authors:  Shantanu V Sule; Muppalla Sukumar; William F Weiss; Anna Marie Marcelino-Cruz; Tyler Sample; Peter M Tessier
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

2.  Phase separation of an IgG1 antibody solution under a low ionic strength condition.

Authors:  Hirotaka Nishi; Makoto Miyajima; Hiroaki Nakagami; Masanori Noda; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2010-04-17       Impact factor: 4.200

3.  Diffusion and sedimentation interaction parameters for measuring the second virial coefficient and their utility as predictors of protein aggregation.

Authors:  Atul Saluja; R Matthew Fesinmeyer; Sabine Hogan; David N Brems; Yatin R Gokarn
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

4.  Application of a PEG precipitation method for solubility screening: a tool for developing high protein concentration formulations.

Authors:  Li Li; Angela Kantor; Nicholas Warne
Journal:  Protein Sci       Date:  2013-06-24       Impact factor: 6.725

5.  Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

Authors:  Xiaoling Wang; Tapan K Das; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

6.  Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule.

Authors:  David Ouellette; Chris Chumsae; Anca Clabbers; Czeslaw Radziejewski; Ivan Correia
Journal:  MAbs       Date:  2013-04-22       Impact factor: 5.857

7.  Taylor dispersion analysis compared to dynamic light scattering for the size analysis of therapeutic peptides and proteins and their aggregates.

Authors:  Andrea Hawe; Wendy L Hulse; Wim Jiskoot; Robert T Forbes
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

8.  A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.

Authors:  Geetha Thiagarajan; Andrew Semple; Jose K James; Jason K Cheung; Mohammed Shameem
Journal:  MAbs       Date:  2016-05-21       Impact factor: 5.857

9.  Investigation of Color in a Fusion Protein Using Advanced Analytical Techniques: Delineating Contributions from Oxidation Products and Process Related Impurities.

Authors:  Hangtian Song; Jianlin Xu; Mi Jin; Chao Huang; Jacob Bongers; He Bai; Wei Wu; Richard Ludwig; Zhengjian Li; Li Tao; Tapan K Das
Journal:  Pharm Res       Date:  2015-12-10       Impact factor: 4.200

Review 10.  Protein aggregation and its impact on product quality.

Authors:  Christopher J Roberts
Journal:  Curr Opin Biotechnol       Date:  2014-08-28       Impact factor: 9.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.